Increased Anti-Inflammatory Therapeutic Potential and Progenitor Marker Expression of Corneal Mesenchymal Stem Cells Cultured in an Optimized Propagation Medium
There is a huge unmet need for new treatment modalities for ocular surface inflammatory disorders (OSIDs) such as dry eye disease and meibomian gland dysfunction. Mesenchymal stem cell therapies may hold the answer due to their potent immunomodulatory properties, low immunogenicity, and ability to m...
Main Authors: | Andrew Hopkinson, Maria Notara, Claus Cursiefen, Laura E. Sidney |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-04-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/09636897241241992 |
Similar Items
-
Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications
by: Thomas Volatier, et al.
Published: (2024-01-01) -
ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation
by: Berbang Meshko, et al.
Published: (2023-06-01) -
Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors
by: Bandeira, Francisco, et al.
Published: (2021) -
Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors
by: Francisco Bandeira, et al.
Published: (2020-01-01) -
The role of lymphatic vessels in corneal fluid homeostasis and wound healing
by: Karina Hadrian, et al.
Published: (2024-01-01)